Menu Search

Successful IPO of HBM-Portfolio Company ARMO BioSciences

California-based immuno-oncology company ARMO BioSciences (Nasdaq: ARMO), a privately held company in the portfolio of HBM Healthcare Investments, took an important step for continued successful corporate development with its IPO on Friday last week.